@article{article, title  = {{Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials}},

 url = {{}},

 year = {{2012}},

 month = {{9}},

 author = {{Lipton A and Fizazi K and Stopeck AT and Henry DH and Brown JE and Yardley DA and Richardson GE and Siena S and Maroto P and Clemens M and Bilynskyy B et al}},

 doi = {{10.1016/j.ejca.2012.08.002}},

 volume = {{48}},

 journal = {{EUROPEAN JOURNAL OF CANCER}},

 issue = {{16}},

 pages = {{3082-3092}},

 note = {{Accessed on 2024/12/21}}}